Phase 3 Readout
CGTX: Phase 3 Topline: Postoperative Dexmedetomidine (PODEX) for Enhanced Recovery in Bowel Surgery: A Double-Blinded, Rand
December 1, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 1, 2027
- Company
- COGNITION THERAPEUTICS INC (CGTX)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: Postoperative Dexmedetomidine (PODEX) for Enhanced Recovery in Bowel Surgery: A Double-Blinded, Rand
- Indication
- Bowel Diseases, Inflammatory; Bowel Surgery; Laparoscopic Abdominal Surgeries